Elevated Capital Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$549 Hold
40
– – ﹤0.01% 812
2026
Q2
$543 Hold
40
– – ﹤0.01% 791
2026
Q1
$240 Hold
40
– – ﹤0.01% 826
2025
Q4
$287 Buy
+40
New +$316 ﹤0.01% 798

Other funds holding OGN

Elevated Capital Advisors's OGN Position: Q3 2026 in Review

Elevated Capital Advisors held its Organon & Co (OGN) position steady in Q3 2026 at 40 shares worth $549. The position accounts for ﹤0.01% of the portfolio, ranked #812.

Elevated Capital Advisors first reported a position in OGN in Q4 2025 and has held it in 4 quarters since. 268 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Elevated Capital Advisors held 40 shares of Organon & Co worth $549 as of Q3 2026.
  • Elevated Capital Advisors left its Organon & Co share count unchanged in Q3 2026.
  • Organon & Co made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q3 2026, its #812 holding.
  • Elevated Capital Advisors first reported a position in Organon & Co in Q4 2025 and has held it in 4 quarters since.
  • 268 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Elevated Capital Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.